A diagnostic test designed to assess cardiovascular health and detect markers associated with heart disease and related conditions.
Manufactured by
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hipro Biotechnology Co., Ltd. CE CIBG
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
POCBio (Nexlab Co., Ltd.)
China · 1 relevant product
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 86 closest product alternatives
Hipro Biotechnology Co., Ltd. CE CIBG · China
Diagnostic reagent kit for cardiovascular disease markers and risk assessment. Detects biomarkers associated with cardiac dysfunction and heart disease.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular genetic test for identifying cardiovascular disease risk factors and drug response markers. Enables personalized treatment strategies for heart disease management.
POCBio (Nexlab Co., Ltd.) · China
A diagnostic test for detecting cardiac markers. This product is used for cardiac health assessment and monitoring.
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products